10/24
12:26 pm
xbio
Xenetic Biosciences (NASDAQ:XBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
Low
Report
Xenetic Biosciences (NASDAQ:XBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
10/8
12:39 pm
xbio
Xenetic Biosciences (NASDAQ:XBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
Medium
Report
Xenetic Biosciences (NASDAQ:XBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
10/3
03:48 pm
xbio
Xenetic Biosciences (NASDAQ:XBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
Low
Report
Xenetic Biosciences (NASDAQ:XBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
11/13
08:45 am
xbio
Form 8-K Xenetic Biosciences, For: Nov 13
Low
Report
Form 8-K Xenetic Biosciences, For: Nov 13
11/12
04:31 pm
xbio
Form 10-Q Xenetic Biosciences, For: Sep 30
Low
Report
Form 10-Q Xenetic Biosciences, For: Sep 30
10/31
04:30 pm
xbio
Form ARS Xenetic Biosciences, For: Dec 31
Medium
Report
Form ARS Xenetic Biosciences, For: Dec 31
10/31
04:20 pm
xbio
Form DEFA14A Xenetic Biosciences,
Medium
Report
Form DEFA14A Xenetic Biosciences,
10/31
04:10 pm
xbio
Form DEF 14A Xenetic Biosciences, For: Dec 11
Medium
Report
Form DEF 14A Xenetic Biosciences, For: Dec 11
10/14
08:49 am
xbio
Form 8-K Xenetic Biosciences, For: Oct 10
Low
Report
Form 8-K Xenetic Biosciences, For: Oct 10
10/14
06:01 am
xbio
Form 424B5 Xenetic Biosciences,
Medium
Report
Form 424B5 Xenetic Biosciences,
10/10
09:28 am
xbio
Form 424B5 Xenetic Biosciences,
High
Report
Form 424B5 Xenetic Biosciences,
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
7/5
Form S-1/A Xenetic Biosciences,
39.2%
6/24
Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock
31.6%
8/5
Form 3 Xenetic Biosciences, For: Jul 19 Filed by: VINOGRADOV ALEXEY ANDREEVICH
9.4%
4/24
Xenetic Biosciences (XBIO) Investor Presentation - Slideshow [Seeking Alpha]
8.9%
4/2
Form 4/A Xenetic Biosciences, For: Sep 26 Filed by: Borisenko Grigory G.
5.1%
7/25
Form SC 13G Xenetic Biosciences, Filed by: Altium Capital Management LP
4.9%
1/21
Form SC 13G/A Xenetic Biosciences, Filed by: Empery Asset Management, LP
4.8%
7/29
Form SC 13D Xenetic Biosciences, Filed by: Opko Health, Inc.
4.1%
9/4
Form SC 13G Xenetic Biosciences, Filed by: SABBY MANAGEMENT, LLC
3.5%
1/13
Form SC 13G/A Xenetic Biosciences, Filed by: SABBY MANAGEMENT, LLC
3.3%
7/16
Form 8-K Xenetic Biosciences, For: Jul 16
-51.6%
7/22
Xenetic Biosciences, Inc. Closes $15.0 Million Underwritten Public Offering and Completes Acquisition of Innovative CAR T Technology Platform
-30.7%
5/15
Form S-1 Xenetic Biosciences,
-27.3%
7/22
Form 8-A12B Xenetic Biosciences,
-19.1%
7/2
Form 8-K Xenetic Biosciences, For: Jun 28
-18.8%
7/12
Form S-1/A Xenetic Biosciences,
-17.8%
7/29
Form SC 13G Xenetic Biosciences, Filed by: Anson Funds Management LP
-14.6%
2/11
Xenetic Biosciences, Inc. to Present at Noble Capital Markets' 16th Annual Investor Conference
-10.3%
10/16
Xenetic Biosciences, Inc. to Present at BIO Investor Forum
-9.7%
11/15
Xenetic Biosciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Corporate Update
-9.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register